University of Texas at Dallas scientists have discovered a previously unknown “housekeeping” process in kidney cells that ejects unwanted content, resulting in cells that rejuvenate themselves and remain functioning and healthy.

The self-renewal process, which is fundamentally different from how other bodily tissues are thought to regenerate, helps explain how, barring injury or disease, the kidneys can remain healthy for a lifetime. The researchers described the mechanism in a study published April 17 in Nature Nanotechnology.

Unlike the liver and skin, where cells divide to create new daughter cells and regenerate the organ, cells in the proximal tubules of the kidney are mitotically quiescent — they do not divide to create new cells. In cases of mild injury or disease, kidney cells do have limited repair capabilities, and stem cells in the kidney can form new kidney cells, but only up to a point, said Dr. Jie Zheng, professor of chemistry and biochemistry in the School of Natural Sciences and Mathematics and co-corresponding author of the study.

“In most scenarios, if kidney cells are severely injured, they will die, and they cannot regenerate,” said Zheng, a Distinguished Chair in Natural Sciences and Mathematics. “Your kidney will just fail sooner or later. That’s a big challenge in health management for kidney disease. All we can do currently is slow down the progression to kidney failure. We cannot easily repair the organ if it’s injured severely or by chronic disease.

“That’s why discovering this self-renewal mechanism is probably one of the most significant findings we’ve made so far. With excellent core facilities and dedicated staff, UTD is a great place to do such cutting-edge research.”

Further research may lead to improvements in nanomedicine and early detection of kidney disease, he said.

An Unexpected Finding

The researchers said their discovery took them by surprise.

For 15 years, Zheng has been investigating the biomedical use of gold nanoparticles as imaging agents, for fundamental understanding of glomerular filtration, for early detection of liver disease, and for targeted delivery of cancer drugs. Part of that work has focused on understanding how gold nanoparticles are filtered by the kidneys and cleared from the body through urine.

Research has shown that gold nanoparticles generally pass unscathed through a structure in the kidney called the glomerulus and then travel into proximal tubules, which make up over 50% of the kidney. Proximal tubular epithelial cells have been shown to internalize the nanoparticles, which eventually escape those cells to be excreted in urine. But just how they escape the cells has been unclear.

In December 2021, Zheng and his chemistry team — research scientist and lead study author Yingyu Huang PhD’20 and co-corresponding author Dr. Mengxiao Yu, research associate professor — were examining gold nanoparticles in proximal tubular tissue samples using an optical microscope, but they switched to one of the University’s electron microscopes (EM) for better resolution.

“Using the EM, we saw gold nanoparticles encapsulated in lysosomes inside of large vesicles in the lumen, which is the space outside the epithelial cells,” Yu said.

Vesicles are small fluid-filled sacks found both inside and outside of cells that transport various substances.

“But we also observed the formation of these vesicles containing both nanoparticles and organelles outside of cells, and it was not something we had seen before,” Yu said.

The researchers found proximal tubular cells that had formed outwardly facing bulges in their luminal membranes that contained not only gold nanoparticles but also lysosomes, mitochondria, endoplasmic reticulum and other organelles typically confined to a cell’s interior. The extruded contents were then pinched off into a vesicle that floated off into the extracellular space.

“At that moment, we knew this was an unusual phenomenon,” Yu said. “This is a new method for cells to remove cellular contents.”

A New Renewal Process

The extrusion-mediated self-renewal mechanism is fundamentally different from other known regenerative processes — such as cell division — and housecleaning tasks like exocytosis. In exocytosis, foreign substances such as nanoparticles are encapsulated in a vesicle inside the cell. Then, the vesicle membrane fuses with the inside of the cell’s membrane, which opens to release the contents to the outside.

“What we discovered is totally different from the previous understanding of how cells eliminate particles. There is no membrane fusion in the extrusion process, which eliminates old content from normal cells and allows the cells to update themselves with fresh contents,” Huang said. “It happens whether foreign nanoparticles are present or not. It’s an intrinsic, proactive process these cells use to survive longer and function properly.”

Zheng said their findings open up new areas of study. For example, epithelial cells, like those in the proximal tubules, are found in other tissues, such as the walls of arteries and in the gut and digestive tract.

“In the field of nanomedicine, we want to minimize accumulation of nanoparticles in the body as much as possible. We don’t want them to get stuck in the kidneys, so it’s very important to understand how nanoparticles are eliminated from the proximal tubules,” Zheng said. “Also, if we could learn how to regulate or monitor this self-renewal process, we might find a way to keep kidneys healthy in patients with high blood pressure or diabetes.

“If we could develop ways to detect the signature of this process noninvasively, perhaps it could be an indicator of early kidney disease.”

The research was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124881, R01DK115986, R01DK126140 and R01DK103363), the National Science Foundation and the Cancer Prevention and Research Institute of Texas.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is melted ice?

Explore More

Clinical trial demonstrates that the ketogenic diet is effective at controlling polycystic kidney disease

It’s official: The ketogenic diet proved to be effective at controlling polycystic kidney disease (PKD) in the first randomized controlled clinical trial of ketogenic metabolic therapy for PKD. “I’m really

New genetic variants for chronic kidney disease identified

Approximately ten per cent of the world’s population currently suffers from chronic kidney disease (CKD). This puts people at increased risk of kidney failure, cardiovascular disease and hospitalisation — and

Higher thiazide doses shown to reduce kidney stone events

Higher thiazide doses are associated with greater reductions in urine calcium, which in turn correlate with fewer symptomatic kidney stone events, according to a Vanderbilt University Medical Center (VUMC) study